For decades, giant mitochondria (known as megamitochondria) have been observed in liver biopsies of patients with alcohol-related liver disease (ALD). However, whether these enlarged organelles represent cellular damage or a protective adaptation remains unclear. The New Perspective paper by Niu et al. provides an updated mechanistic framework to explain how macromitochondria initially protect liver cells but later contribute to inflammation, fibrosis, and liver cancer progression.
This paper integrates several recent original studies from the Ding lab, including mechanistic studies in alcohol-fed mouse models and genetically engineered mice targeting mitochondrial dynamics proteins. Together, these studies will significantly advance the field of mitochondrial biology in liver disease.
Mitochondrial dynamics: the key to giant mitochondria formation
Mitochondria constantly undergo fission and fusion, processes that maintain mitochondrial quality control and metabolic flexibility. The authors highlight that chronic alcohol exposure suppresses the mitochondrial fission protein DRP1, leading to impaired mitochondrial fragmentation and the accumulation of enlarged macromitochondria. Importantly, this finding suggests that megamitochondrial formation in ALD is primarily driven by defective fission rather than excessive fusion.
This represents a major conceptual advance, as previous interpretations primarily considered macromitochondria as a passive pathological consequence of cellular stress.
Surprising discovery: megamitochondria may be initially protective
One of the most interesting findings summarized in this paper is that newly formed megamitochondria may actually improve mitochondrial function during early alcohol exposure. Using bioenergetic analysis and metabolomics, the researchers observed increased mitochondrial oxygen consumption, enhanced NAD+ production, and elevated fatty acid beta-oxidation in alcohol-fed mice.
These data question the conventional view that alcohol uniformly suppresses mitochondrial activity. Instead, hepatocytes appear to be able to mount a transient adaptive metabolic response to alcohol-induced stress through mitochondrial remodeling.
The authors therefore propose a “dual-phase” model.
- Newly formed macromitochondria metabolically adapt and protect.
- Chronically accumulated macromitochondria become maladaptive and become pathogenic.
This transition from adaptive to maladaptive may help explain why only a proportion of heavy alcohol consumers develop severe alcoholic hepatitis and cirrhosis.
Mitophagy failure and chronic liver damage
This study further shows that enlarged megamitochondria are difficult to remove by mitophagy, as mitochondrial fragmentation is required for efficient lysosomal degradation. Over time, damaged megamitochondria accumulate mtDNA mutations and dysfunctional proteins, leading to respiratory problems and the release of mitochondrial danger signals.
Of particular importance is the release of mitochondrial DNA into the cytoplasm, which activates the cGAS-STING innate immune pathway. This signaling cascade promotes inflammatory responses and contributes to chronic liver injury and fibrosis.
Relationship between mitochondrial dysfunction and liver cancer
A major advance highlighted in this paper is the discovery that disruption of mitochondrial dynamics alone can cause spontaneous liver tumor formation. Liver-specific DRP1 knockout mice developed fibrosis, inflammation, and spontaneous liver tumors. In contrast, simultaneous disruption of both mitochondrial fission and fusion pathways partially restored ‘mitochondrial stagnation’ and significantly reduced tumor formation.
The authors also identified alterations in pyrimidine metabolism as another important mechanism linking mitochondrial dysfunction and hepatocellular carcinoma (HCC). Elevated levels of dihydroorotate and orotic acid suggest increased nucleotide synthesis capacity and may support tumor cell proliferation.
Together, these findings establish that mitochondrial dynamics are central regulators associated with metabolism, innate immunity, fibrosis, and liver cancer.
Potential clinical impact
This work has important implications for translation. Pharmacological modulation of mitochondrial dynamics, such as DRP1 inhibition and targeting of the cGAS-STING pathway, may be a promising therapeutic strategy for ALD and HCC.
More broadly, this study highlights that maintaining balanced mitochondrial dynamics, rather than simply increasing fission or fusion, is essential for liver homeostasis.
As the global burden of ALD continues to increase, these findings may open new avenues for precision treatments targeting mitochondrial quality control and metabolic adaptation in chronic liver diseases.
sauce:
Jilin University First Hospital
Reference magazines:
Niu M. others. (2026) Megamitochondria in alcohol-related liver disease and cancer: friend or foe? e Gastroenterology. DOI: 10.1136/egastro-2026-100408. https://egastroenterology.bmj.com/content/4/2/e100408
